IgM plays an important role in induction of collagen-induced arthritis
Open Access
- 22 June 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 149 (3), 579-585
- https://doi.org/10.1111/j.1365-2249.2007.03440.x
Abstract
IgM is one major type of B cell receptor (BCR) expressed on most of the B cells from immature to mature stages. During normal B cell ontogeny, signals transduced through the IgM BCR play an important role in regulating B cell maturation and survival at multiple checkpoints. In addition, IgM BCR is also required for antigen-dependent differentiation and activation of B cells. However, whether IgM BCR-mediated signalling is important for the pathogenesis of autoimmune diseases remains elusive. Using IgM-deficient mice, we examined the effect of absence of IgM on the development of collagen-induced arthritis (CIA), an animal model of rheumatoid arthritis (RA). Compared to their wild-type littermates, IgM-deficient mice were either resistant to arthritis induction or developed significantly less severe arthritis. There was a significant decrease of autoantibody production in IgM-deficient mice, particularly IgG2a antibodies, which is believed to be pathogenic in CIA. Thus, although IgM–/– mice have relatively normal B cell development with IgD BCR replacing IgM BCR, the absence of IgM-mediated signals has a profound impact on the development of CIA, indicating that IgM plays an important role in the development and pathogenesis of autoimmune arthritis and IgM-mediated signalling is critical in the generation of pathogenic autoreactive antibodies.Keywords
This publication has 23 references indexed in Scilit:
- FcγRIV: A Novel FcR with Distinct IgG Subclass SpecificityImmunity, 2005
- B cells in rheumatoid synovitisArthritis Research & Therapy, 2005
- IgD+ IgM- B cells mount immune responses that exhibit altered antibody repertoireEuropean Journal of Immunology, 2004
- Lymphoid Neogenesis in Rheumatoid SynovitisThe Journal of Immunology, 2001
- Anti-Cytokine Therapy for Rheumatoid ArthritisAnnual Review of Medicine, 2000
- B Cell Development in the Spleen Takes Place in Discrete Steps and Is Determined by the Quality of B Cell Receptor–Derived SignalsThe Journal of Experimental Medicine, 1999
- IgMhighCD21high Lymphocytes Enriched in the Splenic Marginal Zone Generate Effector Cells More Rapidly Than the Bulk of Follicular B CellsThe Journal of Immunology, 1999
- IgD can largely substitute for loss of IgM function in B cellsNature, 1998
- Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responsesEuropean Journal of Immunology, 1997
- Surface immunoglobulins of lipopolysaccharide‐stimulated spleen cells The behaviour of IgM, IgD and IgGEuropean Journal of Immunology, 1977